BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 6, 2006
View Archived Issues
SOCS highlighted at a recent meeting as future drug design targets
Read More
Improvements in metabolic risk factors in HIV lipodystrophy study of EG-005
Read More
New Japanese agreement for antipruritic agent TRK-820
Read More
Syntaxin and Allergan to develop novel clostridial endopeptidase-based compounds
Read More
Roswell Park Cancer Institute receives grant to develop aspergillus vaccine
Read More
CUV-1647 studied in phase II trial for erythropoietic protoporphyria
Read More
Roche requests reexamination of CHMP negative opinion for Tarceva
Read More
Major tumor shrinkage observed in study of AS-1411
Read More
Arpida completes enrollment in phase III study of iclaprim in cSSSI
Read More
ICX-PRO studied in phase II trial for diabetic foot ulcers
Read More
Cardioprotective effects of olive oil components
Read More
Clinical data indicate that aspirin and clopidogrel do not interact with TGN-255
Read More
Spectrum offers Q2 overview
Read More
Abbott reports on novel TRPV1 antagonists with efficacy against inflammatory pain
Read More
EUK-189 produces encouraging results for treatment of radiation dermatitis
Read More
European orphan drug status for TRO-19622 in ALS
Read More
Recent Meiji Dairies and NeuroMed patents disclose novel analgesic agents
Read More
Virax files to begin phase I/IIa study of VIR-201 HIV vaccine in S. Africa
Read More
Pivotal Acapodene studies recommended to continue
Read More
New agents for treating neurological disorders disclosed in recent patent literature
Read More
End-of-review meeting for indiplon IR NDA
Read More
Ajinomoto patents novel coagulation factor Xa inhibitors
Read More
Phase III topline results for alvimopan in opioid-induced bowel dysfunction
Read More
The immunosuppressive effects of PARP inhibition enhance cardiac graft survival
Read More
Novel PI3Kdelta inhibitors reported in recent Ono patent
Read More
